Share This
table started by
bioventurist for the BioVenturist Base
There is no user-contributed description yet.
Add More Topics
Save this view to a base, or just for yourself.
about 300 Science or Technology Company topics matching:
Filter this Collection
+
| x name | x image | x Technology Focus | x Products | x Medical focus | x article |
|---|---|---|---|---|---|
| x Amgen |
|
Monoclonal Antibody | Panitumumab | Anemia |
Amgen Inc. (NASDAQ: AMGN, SEHK: 4332) is an international biotechnology company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the largest independent biotech firm. The company employs approximately 14,000 staff...
|
| Small molecule | Darbepoetin alfa | Cardiovascular disease | |||
| Therapeutics | Etanercept | Cancer | |||
| Anakinra | Breast cancer | ||||
| Pegfilgrastim | Prostate cancer | ||||
| more ▼ | |||||
| x Genentech |
|
Personalized medicine | TNKase | Cancer |
Genentech Inc. (NYSE: DNA), a composite of Genetic Engineering Technology, Inc., is a leading biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. Considered the...
|
| Monoclonal Antibody | ACTIVASE | B-cell lymphoma | |||
| Genomics | Nutropin | Colorectal cancer | |||
| Therapeutics | Dornase alfa | Renal cell carcinoma | |||
| Rituximab | Multiple myeloma | ||||
| more ▼ | more ▼ | ||||
| x Novartis AG |
|
Personalized medicine | Visudyne | Cancer |
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008. Novartis is...
|
| Therapeutics | Omalizumab | Prostate cancer | |||
| Basiliximab | Chronic myelogenous leukemia | ||||
| Imatinib | |||||
| x Bayer |
|
Genomics | Alemtuzumab | Cancer |
Bayer AG (German pronunciation: [ˈbaɪə]) (FWB: BAY, TYO: 4863) is a German chemical and pharmaceutical company founded in Barmen, Germany in 1863. Today it is headquartered in Leverkusen, North Rhine-Westphalia, Germany. It is well-known for its...
|
| Therapeutics | Yasmin | Multiple sclerosis | |||
| Betaferon | Diabetes mellitus | ||||
| Kogenate | Reproductive health | ||||
| Nifedipine | Cardiovascular disease | ||||
| more ▼ | more ▼ | ||||
| x CuraGen Corporation | Genomics | Cancer | |||
| x Human Genome Sciences |
|
Genomics | Anti-Trail mAB | Cancer |
Human Genome Sciences (NASDAQ: HGSI) is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on...
|
| Monoclonal Antibody | B-cell lymphoma | ||||
| x Millennium Pharmaceuticals |
|
Genomics | Cancer |
Millennium Pharmaceuticals, Inc., The Takeda Oncology Company is a biopharmaceutical company based in Cambridge, Massachusetts. The Company markets Velcade (bortezomib) for injection, a cancer product, and has a growing clinical development pipeline...
|
|
| Prostate cancer | |||||
| x Myriad Genetics, Inc. | Genomics | Cancer |
Myriad Genetics is a biopharmaceutical company head-quartered in the University of Utah Research Park in Salt Lake City, Utah. It was co-founded in 1992 by Mark Skolnick and Nobel laureate Dr. Walter Gilbert. The company markets cancer predictive...
|
||
| Personalized medicine | Prostate cancer | ||||
| Biomarker | |||||
| x Abraxis BioScience, Inc. | Drug delivery | Abraxane | Cancer |
Abraxis is developing therapeutics for cancer and is bringing forward the first protein based nanoparticle chemotherapeutic compound, ABRAXANE.
|
|
| Nanoparticle Drug Delivery | ABI-008 | Prostate cancer | |||
| ABI-009 | Breast cancer | ||||
| ABI-010 | |||||
| Coroxane | |||||
| x Actelion |
|
Therapeutics | Bosentan | Cancer |
Actelion is developing innovative treatments to serve high unmet medical needs.
|
| Miglustat | |||||
| Iloprost | |||||
| Clazosentan | |||||
| Actelion 1 | |||||
| more ▼ | |||||
| x Advanced Life Sciences Holdings, Inc. | Cancer | ||||
| x Aeterna Zentaris | Therapeutics | Cancer |
Æterna Zentaris Inc. (TSX: AEZ) is a Quebec, Canada-based biopharmaceutical company focused in oncology and endocrine therapy. It has over 250 employees in North America and Europe.
|
||
| Prostate cancer | |||||
| x Ambrilia Biopharma | Cancer | ||||
| Prostate cancer | |||||
| x AmpliMed Corp. | Cancer | ||||
| Prostate cancer | |||||
| x AGI Dermatics | Cancer | ||||
| x Biogen Idec |
|
Monoclonal Antibody | Rituximab | Cancer |
Biogen Idec, Inc. (NASDAQ: BIIB) is a biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen Inc. and San Diego,...
|
| Therapeutics | Ibritumomab tiuxetan | B-cell lymphoma | |||
| Galiximab | Lymphoma | ||||
| Lumiliximab | |||||
| Natalizumab | |||||
| more ▼ | |||||
| x Celgene |
|
Focalin | Cancer |
Celgene Corporation (NASDAQ: CELG) is a manufacturer of drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. As of January 1, 2007, the company had 2441 full-time employees,...
|
|
| REVLIMID | Inflammatory Disease | ||||
| THALOMID | Prostate cancer | ||||
| ALKERAN | |||||
| Pomalidomide | |||||
| more ▼ | |||||
| x Cephalon |
|
Modafinil | Cancer |
Cephalon, Inc. (NASDAQ: CEPH) is a U.S. biopharmaceutical company co-founded in 1987 by Dr. Frank Baldino, Jr., a pharmacologist and former scientist with the DuPont Company, who continues to serve as its chairman and chief executive officer. The...
|
|
| Tiagabine | Prostate cancer | ||||
| Actiq | |||||
| Generic OTFC | |||||
| Fentora | |||||
| more ▼ | |||||
| x Cyclacel |
|
Cancer |
Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC, is a biotechnology firm based in Dundee, Scotland and Short Hills, New Jersey developing cancer drugs and treatments. Cyclacel was founded in 1996 by Professor David Lane, Merlin Ventures and Cancer...
|
||
| x Exelixis |
|
Cancer |
Exelixis is a genomics-based drug discovery company located in South San Francisco, Ca. It works on the development of anti-cancer therapies. Exelixis has several compounds in various stages of FDA approval and is listed on NASDAQ (EXEL).
|
||
| x Genmab | Cancer |
Genmab A/S (OMX: GEN) is a Danish pharmaceutical company, founded in February 1999 and based in Copenhagen. Internationally, it operates through the subsidiaries Genmab BV in Utrecht, The Netherlands, Genmab Ltd in Stevenage, United Kingdom Genmab,...
|
|||
| x Genzyme |
|
Monoclonal Antibody | Alemtuzumab | Cancer |
One
of the world’s foremost biotechnology companies, Genzyme is dedicated
to making a major positive impact on the lives of people with serious
diseases. Founded in Boston in 1981, Genzyme has grown from a small
start-up to a diversified enterprise...
|
| Renagel | Prostate cancer | ||||
| Cerezyme | |||||
| Fabrazyme | |||||
| Aldurazyme | |||||
| more ▼ | |||||
| x Geron Corp. | Stem cell | Cancer |
Geron Corporation is a biotechnology company that specializes in developing and commercialization of products in three specific areas: 1) therapeutic products for cancer that inhibit telomerase; 2) pharmaceuticals that activate telomerase in tissues...
|
||
| Prostate cancer | |||||
| x Gilead Sciences |
|
Ambisome | Cancer |
Gilead Sciences NASDAQ: GILD is a biopharmaceutical company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with...
|
|
| DaunoXome | Cytomegalovirus retinitis | ||||
| Doxil/Caefyx | HIV infection | ||||
| Atripla | Hepatitis B | ||||
| Truvada | Influenza | ||||
| more ▼ | more ▼ | ||||
| x Access Pharmaceuticals Inc. |
|
Nanoparticle Drug Delivery | ProLindac | Cancer | |
| Thiarabine | Prostate cancer | ||||
| Access - Oral Insulin | Breast cancer | ||||
| Angiolix mAB | |||||
| Prodrax | |||||
| more ▼ | |||||
| x Abbott Laboratories | Biomarker | Adalimumab | Cancer |
Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals health care company. It has 72,000 employees and operates in over 130 countries. The corporate headquarters are in Abbott Park, Illinois, located near North Chicago, Illinois.
Abbott...
|
|
| Therapeutics | Prostate cancer | ||||
| x Axcan Pharma |
|
Cancer |
Axcan Pharma Inc. (NASDAQ: AXCA) is a Mont-Saint-Hilaire, Quebec based leading specialty pharmaceutical company that develops, manufactures, markets and distributes a broad line of gastrointestinal (GI) products primarily in North America and Europe...
|
||
| x Actelion Pharmaceuticals US Inc. | Cancer | ||||
| x Active Biotech AB | Therapeutics | Laquinimod | Cancer | ||
| 57-57 | Prostate cancer | ||||
| RhuDex | |||||
| ANYARA | |||||
| TASQ | |||||
| x Adherex Technologies Inc. | Cancer | ||||
| x Advanced Live Sciences Inc. | Cancer | ||||
| x Advanced Viral Research Corp | Cancer | ||||
| x Advaxis Inc. | Cancer | ||||
| Prostate cancer | |||||
| x ADVENTRX Pharmaceuticals, Inc. | ANX-530 | Cancer | |||
| ANX-015 | Breast cancer | ||||
| ANX-016 | |||||
| ANX-514 | |||||
| ANX-201 | |||||
| more ▼ | |||||
| x Aennix Inc. | Cancer | ||||
| x Alchemia Inc. | Cancer | ||||
| x Alfacell Corp | Cancer | ||||
| x Allos Therapeutics Inc. | Cancer | ||||
| x Ambit Biosciences Corp | Cancer | ||||
| x Abrillia BioPharma Inc. | Cancer | ||||
| x Antigen Express Inc. | Cancer | ||||
| x Antisoma Plc. | Cancer | ||||
| Prostate cancer | |||||
| x Aphton Corp. | Cancer | ||||
| x Applied Genetics Inc. | Cancer | ||||
| x Argos Therapeutics Inc. | Cancer | ||||
| x ArQule, Inc. | Cancer | ||||
| x Array BioPharma Inc. | Cancer | ||||
| x Ascenta Therapeutics Inc. | Cancer | ||||
| Prostate cancer | |||||
| x Astex Therapeutics Ltd. | Cancer | ||||
| x AstraZeneca |
|
Therapeutics | Cancer |
AstraZeneca plc (LSE: AZN, NYSE: AZN, OMX: AZN) is an Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries (ICI), as three...
|
|
| Prostate cancer | |||||
| x Attenuon LLC | Cancer | ||||
| Prostate cancer | |||||
| x Avalon Pharmaceuticals, Inc. | Cancer | ||||
| x Avax Technologies Inc. | Cancer | ||||
| x AVEO Pharmaceuticals Inc. | Cancer | ||||
| x AVI BioPharma, Inc. | Cancer | ||||
| Prostate cancer | |||||
| x BTG International Inc. | Cancer | ||||
| x BioCryst Pharmaceuticals In.c | Cancer | ||||
| x Biomira Inc. | Biomarker | Cancer | |||
| x Bionovo, Inc. | Cancer | ||||
| x BioNumerik Pharmaceuticals Inc. | Cancer | ||||
